These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 31728525)

  • 1. Human Transmission of Blastocystis by Fecal Microbiota Transplantation Without Development of Gastrointestinal Symptoms in Recipients.
    Terveer EM; van Gool T; Ooijevaar RE; Sanders IMJG; Boeije-Koppenol E; Keller JJ; Bart A; Kuijper EJ;
    Clin Infect Dis; 2020 Dec; 71(10):2630-2636. PubMed ID: 31728525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gram-Negative Taxa and Antimicrobial Susceptibility after Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
    Steed DB; Wang T; Raheja D; Waldman AD; Babiker A; Dhere T; Kraft CS; Woodworth MH
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33055258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of gut microbial composition associated with the therapeutic efficacy of fecal microbiota transplantation in Clostridium difficile infection.
    Lee PC; Chang TE; Wang YP; Lee KC; Lin YT; Chiou JJ; Huang CW; Yang UC; Li FY; Huang HC; Wu CY; Huang YH; Hou MC
    J Formos Med Assoc; 2022 Sep; 121(9):1636-1646. PubMed ID: 34836663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
    Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
    PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Aging on the Composition of Fecal Microbiota in Donors for FMT and Its Impact on Clinical Outcomes.
    Anand R; Song Y; Garg S; Girotra M; Sinha A; Sivaraman A; Phillips L; Dutta SK
    Dig Dis Sci; 2017 Apr; 62(4):1002-1008. PubMed ID: 28181098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small Intestinal Bacterial Overgrowth: Should Screening Be Included in the Pre-fecal Microbiota Transplantation Evaluation?
    Allegretti JR; Kassam Z; Chan WW
    Dig Dis Sci; 2018 Jan; 63(1):193-197. PubMed ID: 29188472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation.
    Staley C; Kelly CR; Brandt LJ; Khoruts A; Sadowsky MJ
    mBio; 2016 Dec; 7(6):. PubMed ID: 27999162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal Microbiota Transplantation Influences Procarcinogenic Escherichia coli in Recipient Recurrent Clostridioides difficile Patients.
    Nooij S; Ducarmon QR; Laros JFJ; Zwittink RD; Norman JM; Smits WK; Verspaget HW; Keller JJ; Terveer EM; Kuijper EJ;
    Gastroenterology; 2021 Oct; 161(4):1218-1228.e5. PubMed ID: 34126062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal Microbiota Transplantation for Recurrent C difficile Infection During the COVID-19 Pandemic: Experience and Recommendations.
    Khanna S; Tande A; Rubin DT; Khoruts A; Kahn SA; Pardi DS
    Mayo Clin Proc; 2021 Jun; 96(6):1418-1425. PubMed ID: 34088413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor screening for fecal microbiota transplantation with a direct stool testing-based strategy: a prospective cohort study.
    Rondinella D; Quaranta G; Rozera T; Dargenio P; Fancello G; Venturini I; Guarnaccia A; Porcari S; Bibbò S; Sanguinetti M; Gasbarrini A; Masucci L; Cammarota G; Ianiro G
    Microbes Infect; 2024; 26(5-6):105341. PubMed ID: 38679228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection.
    Song Y; Garg S; Girotra M; Maddox C; von Rosenvinge EC; Dutta A; Dutta S; Fricke WF
    PLoS One; 2013; 8(11):e81330. PubMed ID: 24303043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of butyrate-producing microbes of the Firmicutes predicts nonresponse to FMT therapy in patients with recurrent
    Tian H; Cui J; Ye C; Zhao J; Yang B; Xu Y; Ji S; Wang L; Lv X; Ma C; Zhou S; Li N; Wang X; Qin H; Chen Q
    Gut Microbes; 2023; 15(1):2236362. PubMed ID: 37469017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The success of fecal microbial transplantation in
    Park H; Laffin MR; Jovel J; Millan B; Hyun JE; Hotte N; Kao D; Madsen KL
    Gut Microbes; 2019; 10(6):676-687. PubMed ID: 30866714
    [No Abstract]   [Full Text] [Related]  

  • 14. Cross-generational bacterial strain transfer to an infant after fecal microbiota transplantation to a pregnant patient: a case report.
    Wei S; Jespersen ML; Baunwall SMD; Myers PN; Smith EM; Dahlerup JF; Rasmussen S; Nielsen HB; Licht TR; Bahl MI; Hvas CL
    Microbiome; 2022 Nov; 10(1):193. PubMed ID: 36352460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting recurrence of Clostridium difficile infection following encapsulated fecal microbiota transplantation.
    Staley C; Kaiser T; Vaughn BP; Graiziger CT; Hamilton MJ; Rehman TU; Song K; Khoruts A; Sadowsky MJ
    Microbiome; 2018 Sep; 6(1):166. PubMed ID: 30227892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmission and clearance of potential procarcinogenic bacteria during fecal microbiota transplantation for recurrent Clostridioides difficile.
    Drewes JL; Corona A; Sanchez U; Fan Y; Hourigan SK; Weidner M; Sidhu SD; Simner PJ; Wang H; Timp W; Oliva-Hemker M; Sears CL
    JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31578306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Efficacy and Safety of Fecal Microbiota Transplantation for Treatment of Recurrent Clostridioides difficile Infection.
    Perler BK; Chen B; Phelps E; Allegretti JR; Fischer M; Ganapini V; Krajiceck E; Kumar V; Marcus J; Nativ L; Kelly CR
    J Clin Gastroenterol; 2020 Sep; 54(8):701-706. PubMed ID: 32011405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure.
    Lee CH; Chai J; Hammond K; Jeon SR; Patel Y; Goldeh C; Kim P
    Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1731-1735. PubMed ID: 31165961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to prepare stool banks for an appropriate response to the ongoing COVID-19 pandemic: Experiences in the Netherlands and a retrospective comparative cohort study for faecal microbiota transplantation.
    Groenewegen B; van Lingen E; Ooijevaar RE; Wessels E; Feltkamp MCW; Boeije-Koppenol E; Verspaget HW; Kuijper EJ; van Prehn J; Keller JJ; Terveer EM;
    PLoS One; 2022; 17(3):e0265426. PubMed ID: 35298520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Related to Outcomes of Fecal Microbiota Transplantation in Patients with
    Yoon H; Shim HI; Seol M; Shin CM; Park YS; Kim N; Lee DH
    Gut Liver; 2021 Jan; 15(1):61-69. PubMed ID: 32839363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.